Study of ALXN1210 in Complement Inhibitor Treatment-Naïve Adult and Adolescent Participants With Atypical Hemolytic Uremic Syndrome (aHUS)
Condition(s):Atypical Hemolytic Uremic Syndrome (aHUS)Last Updated:April 18, 2023Completed
Hide Studies Not Open or Pending
Condition(s):Atypical Hemolytic Uremic Syndrome (aHUS)Last Updated:April 18, 2023Completed
Condition(s):Paroxysmal Nocturnal Hemoglobinuria (PNH)Last Updated:May 6, 2023Completed
Condition(s):Paroxysmal Nocturnal Hemoglobinuria (PNH)Last Updated:May 11, 2023Completed
Condition(s):Complement Mediated DiseasesLast Updated:January 16, 2018Completed
Condition(s):Atypical Hemolytic Uremic SyndromeLast Updated:May 16, 2023Recruiting
Condition(s):Paroxysmal Nocturnal HemoglobinuriaLast Updated:May 11, 2023Active, not recruiting
Condition(s):Paroxysmal Nocturnal HemoglobinuriaLast Updated:May 11, 2023Recruiting
Condition(s):Paroxysmal Nocturnal HemoglobinuriaLast Updated:March 3, 2023Recruiting
Condition(s):Diabetes MellitusLast Updated:October 4, 2018Completed
Condition(s):PNH; HemolysisLast Updated:September 14, 2022Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.